Abstract
This article will focus on the evolution of robotic-assisted radical cystectomy (RARC) as the treatment for muscle invasive or uncontrolled superficial bladder cancer. Authors describe the current implementation of technology in their patients. The results of published case series and comparative studies on RARC available to date are also reviewed, to identify the surgical, pathological, oncological and quality of life outcomes of RARC.
Original language | English |
---|---|
Pages (from-to) | 341-50 |
Number of pages | 10 |
Journal | Minerva Urologica E Nefrologica |
Volume | 61 |
Issue number | 4 |
Publication status | Published - 2009 |